Correlation Between BioLine RX and Evogene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioLine RX and Evogene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioLine RX and Evogene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioLine RX and Evogene, you can compare the effects of market volatilities on BioLine RX and Evogene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioLine RX with a short position of Evogene. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioLine RX and Evogene.

Diversification Opportunities for BioLine RX and Evogene

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between BioLine and Evogene is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding BioLine RX and Evogene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evogene and BioLine RX is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioLine RX are associated (or correlated) with Evogene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evogene has no effect on the direction of BioLine RX i.e., BioLine RX and Evogene go up and down completely randomly.

Pair Corralation between BioLine RX and Evogene

Assuming the 90 days trading horizon BioLine RX is expected to under-perform the Evogene. In addition to that, BioLine RX is 2.12 times more volatile than Evogene. It trades about -0.08 of its total potential returns per unit of risk. Evogene is currently generating about -0.04 per unit of volatility. If you would invest  155.00  in Evogene on December 1, 2024 and sell it today you would lose (8.00) from holding Evogene or give up 5.16% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy85.71%
ValuesDaily Returns

BioLine RX  vs.  Evogene

 Performance 
       Timeline  
BioLine RX 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days BioLine RX has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Evogene 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Evogene has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Evogene is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.

BioLine RX and Evogene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioLine RX and Evogene

The main advantage of trading using opposite BioLine RX and Evogene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioLine RX position performs unexpectedly, Evogene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evogene will offset losses from the drop in Evogene's long position.
The idea behind BioLine RX and Evogene pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites